Porphyrin excretion in patients with chronic hepatitis C virus infection Excreción de porfirinas e infección crónica por virus G de la hepatitits
Author
dc.contributor.author
Armas-Merino, Rodolfo
Author
dc.contributor.author
Wolff Fernández, Carlos
Author
dc.contributor.author
Parraguez A, Adriana
Author
dc.contributor.author
Soto H., Ramón
Admission date
dc.date.accessioned
2019-03-11T12:50:57Z
Available date
dc.date.available
2019-03-11T12:50:57Z
Publication date
dc.date.issued
1997
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 125, Issue 3, 2018, Pages 279-282
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164119
Abstract
dc.description.abstract
Background: The high prevalence of chronic hepatitis C virus infection in patients with porphyria cutanea tarda, specially in those without family history of the disease, suggests that this could be an acquired disease and one of the most frequent extra hepatic manifestations of hepatitis C virus infection. Aim: To study the excretion of porphyrins and its precursors in cirrhotic patients with and without hepatitis C virus infection. Patients and methods: Eighteen patients with cirrhosis Child-Pough A, eight infected with hepatitis C virus, were studied. Urinary excretion of ∂ aminolevulinic acid, porphobilinogen, coproporphyrins, uroporphyrins and fecal excretion of coproporphyrins and protoporphyrins were measured. Red blood cell protoporphyrin was also measured. Results: There were no differences in the measured parameters between patients with or without hepatitis C virus infection. No patient had uroporphyrin excretion values over the normal range. Some patients had slight elevati